Shuhong Shen
- Hematology top 5%
- Acute Myeloid Leukemia Research 19
- Chronic Myeloid Leukemia Treatments 5
-
- Retinoids in leukemia and cellular processes 5
- Histone Deacetylase Inhibitors Research 5
-
- Acute Lymphoblastic Leukemia research 22
-
- Chronic Lymphocytic Leukemia Research 4
-
- Childhood Cancer Survivors' Quality of Life 11
-
- Neuroblastoma Research and Treatments 5
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (2 papers)Blood (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Shuhong Shen
53 papers receiving 888 citations
Peers
Comparison fields: 5 of 97
- Hematology 226
- Cancer Research 132
- Molecular Biology 467
- Public Health, Environmental and Occupational Health 175
- Genetics 56
Countries citing papers authored by Shuhong Shen
This map shows the geographic impact of Shuhong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuhong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuhong Shen more than expected).
Fields of papers citing papers by Shuhong Shen
This network shows the impact of papers produced by Shuhong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuhong Shen. The network helps show where Shuhong Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuhong Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 17 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 7 | |
| 15 | 2019 | 20 | |
| 16 | 2019 | 14 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 46 | |
| 19 | 2014 | 9 | |
| 20 | 2005 | 70 |
About Shuhong Shen
Shuhong Shen is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 59 papers that have together received 903 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (22 papers), Acute Myeloid Leukemia Research (19 papers), Childhood Cancer Survivors' Quality of Life (11 papers), Retinoids in leukemia and cellular processes (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Neuroblastoma Research and Treatments (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (226 citations), Cancer Research (132 citations) and Molecular Biology (467 citations). Shuhong Shen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hui-liang Xue, Jingyan Tang, Benshang Li, Ci Pan, Yu Liu, Jing Chen, Jinghui Zhang, Yanjing Tang, Long-Jun Gu and Sai‐Juan Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.